Janssen Pharmaceutica SA
5,324.5 FTEJanssen Pharmaceutica reported revenue of €21.8bn for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 22 Jun 2026), with 5,324.5 full-time equivalents.
By total assets for 2025, Janssen Pharmaceutica is the largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Janssen Pharmaceutica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +2 % Equity +33 % Total assets +12 % Headcount (avg FTE) +5 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Janssen Pharmaceutica's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €21.8bn | ||||
| Net result | €1.46bn | ||||
| Equity | €11.7bn | ||||
| Cash | €24.7m | ||||
| EBITDA | €4.11bn | ||||
| Total assets | €21.6bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
Janssen Pharmaceutica's financial analysis
- Solvency54.1%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Janssen Pharmaceutica
16 active director(s) in the register.
and 10 more
Janssen Pharmaceutica's shareholders and holdings →Janssen Pharmaceutica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.834.160
- VAT number
- BE0403834160
- Peppol
- Registered · 0208:0403834160 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Oct 1934
- Registered office
- 2340 Beerse
- Size
- Large · 5,324.5 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Janssen Pharmaceutica (SA) has been based in Beerse since 1934, active in: manufacture of medicaments. For 2025, it reports revenue of €21.8bn, a net profit of €1.46bn and equity of €11.7bn. With 5,324.5 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 54.1%, above the median of its sector (47.2%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Janssen Pharmaceutica
Companies in the same business, of comparable size and area, outside its group.
- UCB Pharma Manufacture of pharmaceutical preparations Anderlecht · balance sheet €20.7bn
- Boehringer Ingelheim SComm Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €1.60bn
- Organon Heist Manufacture of pharmaceutical preparations Heist-op-den-Berg · balance sheet €349.6m
- PolyPeptide Manufacture of basic pharmaceutical products Braine-l'Alleud · balance sheet €331.7m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- Baxter Manufacture of pharmaceutical preparations Lessines · balance sheet €160.0m
Frequently asked questions about Janssen Pharmaceutica
What is the revenue of Janssen Pharmaceutica?
According to the 2025 annual accounts filed with the NBB, the revenue of Janssen Pharmaceutica amounts to 21,788,177,348 €.
What is the VAT number of Janssen Pharmaceutica?
In Belgium, the VAT number is the company number prefixed with BE: BE0403834160 for Janssen Pharmaceutica, if the company is VAT-registered. Its company number (CBE) is 0403.834.160.
Where is the registered office of Janssen Pharmaceutica?
According to the CBE register, the registered office of Janssen Pharmaceutica is in 2340 Beerse.
What is the equity of Janssen Pharmaceutica?
At the close of the 2025 financial year, the equity of Janssen Pharmaceutica amounts to 11,677,693,137 €, a solvency of 54.1% of total assets.
How many people work at Janssen Pharmaceutica?
5,324.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Janssen Pharmaceutica?
The register lists 16 active mandates at Janssen Pharmaceutica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Janssen Pharmaceutica within its sector?
By total assets for 2025, Janssen Pharmaceutica is the largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of Janssen Pharmaceutica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →